Health
New evidence shows microbe strain can orally treat systemic inflammation in psoriasis – Science Codex
LUGANO, 29 October, 2020 – Disruptive innovations in psoriasis are leading the way at EADV’s 29th Congress, EADV Virtual. New data published today shows the first clinical evidence of modulating systemic inflammation by oral delivery of a non-living single strain commensal microbe. This new therapeutic class brings hope for a completely new way of treating this debilitating skin condition (1).
The phase 1b clinical study, by Evelo Biosciences, evaluated EDP1815, a preparation of a non-living single…
-
Business20 hours agoBroker names 2 small cap ASX shares to buy for big returns
-
Noosa News20 hours agoMin Woo Lee, Adam Scott and Cameron Smith in the mix after Australian PGA opening round in Brisbane
-
Business19 hours agoThese top ASX 200 stocks could rise 25% to 60%
-
Noosa News19 hours agoDid AI write your accounting expert’s report? – Proctor